(Q43668148)

English

Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction

scientific article published in July 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

substance dependence

0 references

tetrahydrocannabinol

0 references

0 references

author name string

Lamarque S

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Taghzouti K

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Simon H

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

118-129

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Regional brain homovanillic acid following delta 9-tetrahydrocannabinol and cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Potentiation of amphetamine-induced arousal by starvation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

THC does not affect striatal dopamine release: Microdialysis in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

delta 9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Repeated administration of delta9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

The mechanism of action of ? 9 -tetrahydrocannabinol on body temperature in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Repeated corticosterone administration sensitizes the locomotor response to amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Sensitization to the psychomotor effects of amphetamine and morphine induced by food restriction depends on corticosterone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Mesolimbic dopaminergic decline after cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

The role of dopamine in drug abuse viewed from the perspective of its role in motivation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Cannabinoids and the hippocampal glucocorticoid receptor: recent findings and possible significance

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Delta 9-tetrahydrocannabinol: aversive effects in rat at high doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

The effect of intravenous administration of delta-9-tetrahydrocannabinol on the activity of A10 dopamine neurons recorded in vivo in anesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

1-Δ 9 -Tetrahydrocannabinol: Neurochemical and Behavioral Effects in the Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Acute effects of two tetrahydrocannabinols (?9-THC and ?8-THC) on water intake in water deprived rats: Implications for behavioral studies on marijuana compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Stages in adolescent involvement in drug use

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Cellular and molecular mechanisms of drug dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Effect of early exposure to delta-9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Inhibition of Normal Growth by Chronic Administration of Δ 9 -Tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Pharmacological and biochemical interactions between opioids and cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Factors that predict individual vulnerability to amphetamine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Corticosterone levels determine individual vulnerability to amphetamine self-administration

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Schedule-induced self-injection of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Influence of tetrahydrocannabinols (delta8-THC and delta9-THC) on body weight, food, and water intake in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Acute and chronic effects of delta9-tetrahydrocannabinol on food intake by rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Interindividual differences in active and passive behaviors in the forced-swimming test: implications for animal models of psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Self-administration of Δ9-tetrahydrocannabinol by rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Biphasic nature of the effects of Δ9-tetrahydrocannabinol on body temperature and brain amines of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Relationship between body temperature and brain monoamines during the development of tolerance to ?9-tetrahydrocannabinol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Tolerance to the hypothermic and aggression-attenuating effect of delta 8 - and delta 9 - tetrahydrocannabinol in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

The effects of morphine and ?-9-tetrahydrocannabinol on motor activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Effects of 9 -tetrahydrocannabinol and ethyl alcohol on adjunctive behavior and the lateral hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

Patterns of drug use from adolescence to young adulthood: III. Predictors of progression

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

The effects of Δ9-tetrahydrocannabinol, cannabidiol, and shock on plasma corticosterone concentrations in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

based on heuristic

inferred from DOI database lookup

THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900039-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0028-3908(01)00039-9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43668148&oldid=2102400655"